ORYN THERAPEUTICS, LLC
Biotechnology - , California, United States
ORYN THERAPEUTICS, LLC Employees
James Mullaney
Chief Financial Officer / Chief Operating Officer (Biotech/Life Sciences)
ORYN THERAPEUTICS, LLC Senior Management
James Mullaney
Chief Financial Officer / Chief Operating Officer (Biotech/Life Sciences)
ORYN THERAPEUTICS, LLC Details
Oryn Therapeutics is a clinical-stage company developing a new class of drug candidates, Orynotides. These proprietary drug candidates are engineered, stable, cyclic peptides with very low immunogenicity and toxicity. They modulate pathologic inflammation and have proven effective in animal models of autoimmune and chronic inflammatory diseases such as rheumatoid arthritis and ulcerative colitis. They have proven effective in preclinical cancer models and augment natural host defense, functioning as host-directed anti-infectives against drug resistant pathogens.
ORYN THERAPEUTICS, LLC Technologies
Email Providers
Outlook
Load Balancers
Apache
CMS
WordPress.org
Fonts
Google Font API
Hosting
GoDaddy Hosting
Other
Mobile Friendly